Icu Medical Inc (ICUI) Institutional Ownership & 13F Filings (Q2 2026)

ICUI ranks #2220 out of 37503 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

286 institutions disclose a position in ICUI, but none treat it as a major bet — even Defilade Capital Management, L.P., its most concentrated holder, allocates just 2.1% of its own portfolio to it.

Ken Griffin has added to its ICUI position for two straight quarters, increasing it by $52.3M to reach $83.0M today.

Defilade Capital Management, L.P. has trimmed its ICUI position for two straight quarters, cutting it by $33.1M while still holding $15.5M.

ICUI is down 0% today, but institutions show net buying of $695.9M this quarter — a divergence between today's price move and the underlying institutional flow.

ICUI posted net income of $30.1M over the trailing twelve months, and currently trades at a P/E of 144.9.

• Profitable — net income of $30.1M over the trailing twelve months
• Revenue declined 7.3% year over year
• Net income improved year over year, from -$36.9M to $30.1M
• Generated $179.8M in positive operating cash flow
• Current ratio of 2.39x — enough short-term assets to cover short-term liabilities
• Liabilities run 1.91x equity — within a conventional range